这是一篇来自已证抗体库的有关人类 CEACAM6的综述，是根据8篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CEACAM6 抗体。
CEACAM6 同义词: CD66c; CEAL; NCA; carcinoembryonic antigen-related cell adhesion molecule 6; Cluster of Differentiation 66c; carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen); normal cross-reacting antigen

赛默飞世尔
兔 多克隆
  • 免疫组化-石蜡切片; 人类; 1:1000; 图 4
赛默飞世尔 CEACAM6抗体（Thermo Fisher Scientific, PA5-29551)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:1000 (图 4). J Proteome Res (2017) ncbi
美天旎
小鼠 单克隆（TET2）
  • 流式细胞仪; 猕猴; 图 1a
美天旎 CEACAM6抗体（Miltenyi Biotec, TET2)被用于被用于流式细胞仪在猕猴样品上 (图 1a). J Immunol (2017) ncbi
BioLegend
小鼠 单克隆（9A6）
  • 免疫印迹; 人类
BioLegend CEACAM6抗体（Covance, SIG3750)被用于被用于免疫印迹在人类样品上. Tumour Biol (2015) ncbi
赛信通（上海）生物试剂有限公司
小鼠 单克隆（CB30）
  • 免疫组化-石蜡切片; 小鼠; 图 4
赛信通（上海）生物试剂有限公司 CEACAM6抗体（Cell Signaling, CB30)被用于被用于免疫组化-石蜡切片在小鼠样品上 (图 4). Oncoimmunology (2016) ncbi
小鼠 单克隆（CB30）
  • 免疫印迹; 小鼠; 1:500
赛信通（上海）生物试剂有限公司 CEACAM6抗体（Cell Signaling Technologies, 2383)被用于被用于免疫印迹在小鼠样品上浓度为1:500. Cardiovasc Diabetol (2015) ncbi
小鼠 单克隆（CB30）
  • 免疫印迹; 小鼠; 1:500
赛信通（上海）生物试剂有限公司 CEACAM6抗体（Cell Signaling Technologies, 2383)被用于被用于免疫印迹在小鼠样品上浓度为1:500. BMC Endocr Disord (2015) ncbi
小鼠 单克隆（CB30）
  • 免疫印迹; 人类
赛信通（上海）生物试剂有限公司 CEACAM6抗体（Cell Signaling, 2383)被用于被用于免疫印迹在人类样品上. Tumour Biol (2015) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆（KOR-SA3544）
  • 流式细胞仪; 人类; 1:25; 图 1b
贝克曼库尔特实验系统(苏州)有限公司 CEACAM6抗体（Beckman Coulter, KOR-SA3544)被用于被用于流式细胞仪在人类样品上浓度为1:25 (图 1b). Cell Transplant (2017) ncbi
碧迪BD
小鼠 单克隆（B6.2/CD66）
  • 流式细胞仪; 人类; 图 st1
碧迪BD CEACAM6抗体（BD, 551478)被用于被用于流式细胞仪在人类样品上 (图 st1). Exp Cell Res (2016) ncbi
文章列表
  1. Codreanu S, Hoeksema M, Slebos R, Zimmerman L, Rahman S, Li M, et al. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma. J Proteome Res. 2017;16:3266-3276 pubmed 出版商
  2. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed 出版商
  3. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed 出版商
  4. Wang L, Ma N, Okamoto S, Amaishi Y, Sato E, Seo N, et al. Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome. Oncoimmunology. 2016;5:e1211218 pubmed
  5. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  6. He J, Quintana M, Sullivan J, L Parry T, J Grevengoed T, Schisler J, et al. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. Cardiovasc Diabetol. 2015;14:97 pubmed 出版商
  7. Quintana M, He J, Sullivan J, Grevengoed T, Schisler J, Han Y, et al. Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet. BMC Endocr Disord. 2015;15:36 pubmed 出版商
  8. Aqil M, Elseth K, Arjunakani A, Nebres P, Amegashie C, Thanki D, et al. A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties. Tumour Biol. 2015;36:1871-9 pubmed 出版商